{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:01:09Z","timestamp":1790395269228,"version":"4.1.0"},"reference-count":42,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,9,25]]},"DOI":"10.1253\/circj.cj-25-1168","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:11:20Z","timestamp":1788300680000},"page":"1368-1377","source":"Crossref","is-referenced-by-count":1,"title":["Association Between Changes in Serum N-Terminal Pro B-Type Natriuretic Peptide Levels and All-Cause and Cause-Specific Mortality\u3000\u2015 The Hisayama Study \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Asahi","family":"Kato","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Oishi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Maezono","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Furuta","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hata","sequence":"additional","affiliation":[{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Ago","sequence":"additional","affiliation":[{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Ninomiya","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. <i>Heart<\/i> 2006; 92: 843\u2013849.","DOI":"10.1136\/hrt.2005.071233"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes-Genis A, Butler J, et al. Natriuretic peptides: Role in the diagnosis and management of heart failure: A scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. <i>Eur J Heart Fail<\/i> 2023; 25: 616\u2013631.","DOI":"10.1002\/ejhf.2848"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. <i>Circulation<\/i> 2022; 145: e895\u2013e1032, doi:10.1161\/cir.0000000000001063.","DOI":"10.1161\/CIR.0000000000001063"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, et al. N-Terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: The Hisayama Study. <i>Arterioscler Thromb Vasc Biol<\/i> 2011; 31: 2997\u20133003.","DOI":"10.1161\/ATVBAHA.111.223669"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sasaki T, Oishi E, Nagata T, Sakata S, Chen S, Furuta Y, et al. N-Terminal pro-B-type natriuretic peptide and incident CKD. <i>Kidney Int Rep<\/i> 2021; 6: 976\u2013985.","DOI":"10.1016\/j.ekir.2021.01.006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mutlu U, Ikram MA, Hofman A, de Jong PTVM, Klaver CCW, Ikram MK. N-Terminal pro-B-type natriuretic peptide is related to retinal microvascular damage: The Rotterdam Study. <i>Arterioscler Thromb Vasc Biol<\/i> 2016; 36: 1698\u20131702.","DOI":"10.1161\/ATVBAHA.116.307545"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Azzo JD, Dib MJ, Zagkos L, Zhao L, Wang Z, Chang CP, et al. Proteomic associations of NT-proBNP (N-terminal pro-B-type natriuretic peptide) in heart failure with preserved ejection fraction. <i>Circ Heart Fail<\/i> 2024; 17: e011146, doi:10.1161\/CIRCHEARTFAILURE.123.011146.","DOI":"10.1161\/CIRCHEARTFAILURE.123.011146"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Nagata T, Ohara T, Hata J, Sakata S, Furuta Y, Yoshida D, et al. NT-proBNP and risk of dementia in a general Japanese elderly population: The Hisayama Study. <i>J Am Heart Assoc<\/i> 2019; 8: e011652, doi:10.1161\/JAHA.118.011652.","DOI":"10.1161\/JAHA.118.011652"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Prokopidis K, Morwani-Mangnani J, McDowell G, Lip GYH, Venturelli M, Sankaranarayanan R, et al. Sarcopenia is linked to higher levels of B-type natriuretic peptide and its N-terminal fragment in heart failure: A systematic review and meta-analysis. <i>Eur Geriatr Med<\/i> 2024; 15: 893\u2013901.","DOI":"10.1007\/s41999-024-00950-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Januzzi JL, Troughton R. Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management. <i>Circulation<\/i> 2013; 127: 500\u2013507.","DOI":"10.1161\/CIRCULATIONAHA.112.120485"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jhund PS, Anand IS, Komajda M, Claggett BL, McKelvie RS, Zile MR, et al. Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: An analysis of the I-Preserve study. <i>Eur J Heart Fail<\/i> 2015; 17: 809\u2013817.","DOI":"10.1002\/ejhf.274"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zile MR, Claggett BL, Prescott MF, McMurray JJV, Packer M, Rouleau JL, et al. Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure. <i>J Am Coll Cardiol<\/i> 2016; 68: 2425\u20132436.","DOI":"10.1016\/j.jacc.2016.09.931"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Daniels LB, Clopton P, deFilippi CR, Sanchez OA, Bahrami H, Lima JAC, et al. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA). <i>Am Heart J<\/i> 2015; 170: 1170\u20131183.","DOI":"10.1016\/j.ahj.2015.09.010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. deFilippi CR, Christenson RH, Gottdiener JS, Kop WJ, Seliger SL. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. <i>J Am Coll Cardiol<\/i> 2010; 55: 441\u2013450.","DOI":"10.1016\/j.jacc.2009.07.069"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Eggers KM, Venge P, Lind L. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged \u226570 years. <i>Am J Cardiol<\/i> 2013; 111: 131\u2013136.","DOI":"10.1016\/j.amjcard.2012.08.058"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Jia X, Rifai MA, Hoogeveen R, Echouffo-Tcheugui JB, Shah AM, Ndumele CE, et al. Association of long-term change in N-terminal pro-B-type natriuretic peptide with incident heart failure and death. <i>JAMA Cardiol<\/i> 2023; 8: 222\u2013230.","DOI":"10.1001\/jamacardio.2022.5309"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Myhre PL, Claggett B, Yu B, Skali H, Solomon SD, R\u00f8sj\u00f8 H, et al. Sex and race differences in N-terminal pro-B-type natriuretic peptide concentration and absolute risk of heart failure in the community. <i>JAMA Cardiol<\/i> 2022; 7: 623\u2013631.","DOI":"10.1001\/jamacardio.2022.0680"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ninomiya T. Japanese legacy cohort studies: The Hisayama Study. <i>J Epidemiol<\/i> 2018; 28: 444\u2013451.","DOI":"10.2188\/jea.JE20180150"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, et al. Secular trends in cardiovascular disease and its risk factors in Japanese: Half-century data from the Hisayama Study (1961\u20132009). <i>Circulation<\/i> 2013; 128: 1198\u20131205.","DOI":"10.1161\/CIRCULATIONAHA.113.002424"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yeo KT, Wu AHB, Apple FS, Kroll MH, Christenson RH, Lewandrowski KB, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. <i>Clin Chim Acta<\/i> 2003; 338: 107\u2013115.","DOI":"10.1016\/j.cccn.2003.08.016"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Schou M, Gustafsson F, Nielsen PH, Madsen LH, Kjaer A, Hildebrandt PR. Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state. <i>Eur J Heart Fail<\/i> 2007; 9: 68\u201374.","DOI":"10.1016\/j.ejheart.2006.05.001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society, and Writing Committee of the Universal Definition of Heart Failure. <i>J Card Fail<\/i> 2021; 27: 387\u2013413.","DOI":"10.1002\/ejhf.2115"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, et al. JCS\/JHFS 2025 Guideline on diagnosis and treatment of heart failure. <i>Circ J<\/i> 2025; 89: 1278\u20131444.","DOI":"10.1253\/circj.CJ-25-0002"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, et al. 2013 ACC\/AHA Guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. <i>Circulation<\/i> 2014; 129(Suppl 2): S49\u2013S73, doi:10.1161\/01.cir.0000437741.48606.98.","DOI":"10.1161\/01.cir.0000437741.48606.98"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Uno H, Cai T, Pencina MJ, D\u2019Agostino RB, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. <i>Stat Med<\/i> 2011; 30: 1105\u20131117.","DOI":"10.1002\/sim.4154"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Pencina MJ, D\u2019Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. <i>Stat Med<\/i> 2011; 30: 11\u201321.","DOI":"10.1002\/sim.4085"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Pencina MJ, D\u2019Agostino RB Sr, D\u2019Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. <i>Stat Med<\/i> 2008; 27: 157\u2013172.","DOI":"10.1002\/sim.2929"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Numata G, Takimoto E. Cyclic GMP and PKG signaling in heart failure. <i>Front Pharmacol<\/i> 2022; 13: 792798, doi:10.3389\/fphar.2022.792798.","DOI":"10.3389\/fphar.2022.792798"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. <i>Endocr Rev<\/i> 2006; 27: 47\u201372.","DOI":"10.1210\/er.2005-0014"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. McKechnie DGJ, Papacosta AO, Lennon LT, Welsh P, Whincup PH, Wannamethee SG. Inflammatory markers and incident heart failure in older men: The role of NT-proBNP. <i>Biomark Med<\/i> 2021; 15: 413\u2013425.","DOI":"10.2217\/bmm-2020-0669"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Fish-Trotter H, Ferguson JF, Patel N, Arora P, Allen NB, Bachmann KN, et al. Inflammation and circulating natriuretic peptide levels. <i>Circ Heart Fail<\/i> 2020; 13: e006570, doi:10.1161\/CIRCHEARTFAILURE.119.006570.","DOI":"10.1161\/CIRCHEARTFAILURE.119.006570"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Welsh P, Tuckwell K, McInnes IB, Sattar N. Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis. <i>Atherosclerosis<\/i> 2016; 254: 167\u2013171.","DOI":"10.1016\/j.atherosclerosis.2016.10.016"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Tanaka A, Yoshida H, Kawaguchi A, Oyama J, Kotooka N, Toyoda S, et al. N-Terminal pro-brain natriuretic peptide and associated factors in the general working population: A baseline survey of the Uranosaki cohort study. <i>Sci Rep<\/i> 2017; 7: 5810, doi:10.1038\/s41598-017-06090-6.","DOI":"10.1038\/s41598-017-06090-6"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Moro C, Lafontan M. Natriuretic peptides and cGMP signaling control of energy homeostasis. <i>Am J Physiol Heart Circ Physiol<\/i> 2013; 304: H358\u2013H368.","DOI":"10.1152\/ajpheart.00704.2012"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessi-Fulgheri P, Zhang C, et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. <i>J Clin Invest<\/i> 2012; 122: 1022\u20131036.","DOI":"10.1172\/JCI59701"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Rahsepar AA, Bluemke DA, Habibi M, Liu K, Kawel-Boehm N, Ambale-Venkatesh B, et al. Association of pro-B-type natriuretic peptide with cardiac magnetic resonance-measured global and regional cardiac function and structure over 10 years: The MESA study. <i>J Am Heart Assoc<\/i> 2021; 10: e019243, doi:10.1161\/JAHA.120.019243.","DOI":"10.1161\/JAHA.120.019243"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Spannella F, Giulietti F, Bordicchia M, Burnett JC Jr, Sarzani R. Association between cardiac natriuretic peptides and lipid profile: A systematic review and meta-analysis. <i>Sci Rep<\/i> 2019; 9: 19178, doi:10.1038\/s41598-019-55770-y.","DOI":"10.1038\/s41598-019-55770-y"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Cao C, Yang L, Nohria A, Mayer EL, Partridge AH, Ligibel JA. Association of N-terminal pro-brain natriuretic peptide with survival among US cancer survivors. <i>J Natl Cancer Inst<\/i> 2024; 116: 938\u2013947.","DOI":"10.1093\/jnci\/djae008"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Takahashi S, Tanaka T, Suzuki Y, Yoshida N, Hitaka M, Ishii S, et al. Association between malnutrition, low muscle mass, elevated NT-ProBNP levels, and mortality in hemodialysis patients. <i>Nutrients<\/i> 2025; 17: 1896, doi:10.3390\/nu17111896.","DOI":"10.3390\/nu17111896"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ohsaki Y, Gross AJ, Le PT, Oie H, Johnson BE. Human small cell lung cancer cells produce brain natriuretic peptide. <i>Oncology<\/i> 1999; 56: 155\u2013159.","DOI":"10.1159\/000011957"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Shi C, van der Wal HH, Sillj\u00e9 HHW, Dokter MM, van den Berg F, Huizinga L, et al. Tumour biomarkers: Association with heart failure outcomes. <i>J Intern Med<\/i> 2020; 288: 207\u2013218.","DOI":"10.1111\/joim.13053"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Ledwidge M, Gallagher J, Conlon C, Tallon E, O\u2019Connell E, Dawkins I, et al. Natriuretic peptide-based screening and collaborative care for heart failure: The STOP-HF randomized trial. <i>JAMA<\/i> 2013; 310: 66\u201374.","DOI":"10.1001\/jama.2013.7588"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/10\/90_CJ-25-1168\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:30:06Z","timestamp":1790393406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/10\/90_CJ-25-1168\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-1168","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"CJ-25-1168"}}